Verve

Developer of gene-editing therapies for treating coronary artery disease

placeCambridge, Massachusetts, United States calendar_todayFounded 2018 groups255 employees language vervetx.com

Registered entities

Investor mix

16 investors on record; lead investors include Google Ventures, Wellington, Casdin Capital; 3 have since exited.

Investor typeCountShare
Venture capital956%
Bank & private debt16%
Other / undisclosed638%
Coming soon